Not Yet Recruiting PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT06197763

Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation. (MYSTIC)

Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation (MYSTIC) Pilot Study.

Sponsor: St. Boniface Hospital

Conditions Fontan Circulation

Interventions Colesevelam Control Arm

Updated 4 times since 2024 Last updated: Apr 15, 2024 Started: Jun 1, 2024 Primary completion: Nov 1, 2025 Completion: May 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Fontan Circulation and is currently actively recruiting participants. St. Boniface Hospital leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
May 2024 — Jul 2024 [monthly]

Not Yet Recruiting PHASE1_PHASE2
Feb 2024 — May 2024 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. Boniface Hospital

Data source: St. Boniface Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.